表紙
市場調查報告書
商品編碼
750170

關鍵意見領袖 (KOL)的見解:發炎性腸道疾病 (IBD) 相關適應性的臨床實驗設計

KOL Perspectives: Adaptive Trial Designs in IBD

出版日期: | 出版商: GlobalData | 英文 27 Pages | 訂單完成後即時交付

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供發炎性腸道疾病 (IBD) 治療藥方面迄今的臨床實驗成果,及今後適應性出色的臨床實驗設計方式,提供市場趨勢預測相關分析,產業的關鍵意見領袖 (KOL) 的訪談,彙總其結果為您概述為以下內容。

目錄

  • 摘要整理
  • 背景情況
  • 研究小組組成
  • 調查結果和其意義

附錄

目錄
Product Code: GDHC057SP

This KOL Insight briefing focuses on KOLs views of Adaptive trial designs in IBD.

Questions topics:

  • Current challenges in IBD clinical trials
  • Adaptive Phase II/III trial designs
  • Guselkumab's Phase II/III trial in Crohn's disease
  • Novel clinical trials in IBD

Key Highlights:

  • Most KOLs highlighted that recruitment is the greatest challenge in IBD clinical trials, both across Crohn's disease & UC
  • Most KOLs flagged Phase II/III trials could accelerate development, but may limit ability to analyze data & adapt trial design
  • Most KOLs cited 8-12 weeks as being the minimum duration of a Phase II trial in IBD, with open-label extensions favored by all KOLs.

Scope:

  • The insight briefing is based on Sociable Pharma's analysis of primary research with our IBD key opinion leaders (KOLs).

In total, we conducted interviews with 10 KOLs -

  • 5 Europe-based & 5 N. America-based
  • Interviews performed during July 2018

KOL data is analyzed to produce -

  • Charts summarizing KOL opinions
  • Chart call-outs of key information & details
  • KOL quotes
  • Summary of KOL reporting trends
  • Insight from Sociable Pharma's analysts

Reasons to buy:

  • Combines Qualitative & semi-quantitative insight from key opinion leaders on Adaptive trial designs in IBD
  • Includes insight & recommendations from our disease-specific healthcare analysts
  • Utilizes independent expert viewpoints to validate the impact of new clinical data & emerging trends on management of IBD
  • Provides cost-effective support for your advisory boards, with topics acting as a catalyst for further expert discussion.

Table of Contents

  • Executive Summary
  • Background
  • Research Panel Composition
  • Results & Implications
  • Appendix